Autoimmune disease in people with multiple sclerosis and their relatives: A systematic review and meta-analysis

Journal of Neurology

Volumn 260, Issue 5, 2013, Pages 1272-1285

  Dobson, Ruth ^a   Giovannoni, Gavin ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Autoimmune disease; Diabetes; Inflammatory bowel disease; Multiple sclerosis; Thyroid

Indexed keywords

AUTOIMMUNE DISEASE; BIBLIOGRAPHIC DATABASE; FAMILY; GENETICS; HUMAN; IMMUNOLOGY; META ANALYSIS; MULTIPLE SCLEROSIS; PSYCHOLOGICAL ASPECT; REVIEW; STATISTICS; PSYCHOLOGY; STATISTICS AND NUMERICAL DATA;

AUTOIMMUNE DISEASES; DATABASES, BIBLIOGRAPHIC; FAMILY; HUMANS; MULTIPLE SCLEROSIS;

EID: 84891379060     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-012-6790-1     Document Type: Review

References (51)

1. Ebers G (2008) Environmental factors and multiple sclerosis. Lancet Neurol 7(3):268-277.
2. Ramagopalan SV, Dobson R, Meier UC, Giovannoni G (2010) Multiple sclerosis: risk factors, prodromes, and potential causal pathways. Lancet Neurol 9(7):727-739.
3. Sawcer S, Hellenthal G, Pirinen M, Spencer CC, Patsopoulos NA, Moutsianas L et al (2011) Genetic risk and a primary role for cellmediated immune mechanisms in multiple sclerosis. Nature 476(7359):214-219.
4. Moroni L, Bianchi I, Lleo A (2012) Geoepidemiology, gender and autoimmune disease. Autoimmun Rev 11(6-7):A386-A392.
5. Willer CJ, Dyment DA, Risch NJ, Sadovnick AD, Ebers GC (2003) Twin concordance and sibling recurrence rates in multiple sclerosis. Proc Natl Acad Sci USA 100(22):12877-12882.
6. Disanto G, Ramagopalan SV (2012) Multiple sclerosis and comorbid autoimmune disease: The final nail in the coffin Mult Scler 18(10):1370-1371.
7. Roshanisefat H, Bahmanyar S, Hillert J, Olsson T, Montgomery S (2012) Shared genetic factors may not explain the raised risk of comorbid inflammatory diseases in multiple sclerosis. Mult Scler 18(10):1430-1436.
8. Nielsen NM, Westergaard T, Frisch M, Rostgaard K, Wohlfahrt J, Koch-Henriksen N et al (2006) Type 1 diabetes and multiple sclerosis: A Danish population-based cohort study. Arch Neurol 63(7):1001-1004.
9. Nielsen NM, Frisch M, Rostgaard K, Wohlfahrt J, Hjalgrim H, Koch-Henriksen N et al (2008) Autoimmune diseases in patients with multiple sclerosis and their first-degree relatives: A nationwide cohort study in Denmark. Mult Scler 14(6):823-829.
10. Somers EC, Thomas SL, Smeeth L, Hall AJ (2009) Are individuals with an autoimmune disease at higher risk of a second autoimmune disorder Am J Epidemiol 169(6):749-755.
11. Langer-Gould A, Albers KB, Van Den Eeden SK, Nelson LM (2010) Autoimmune diseases prior to the diagnosis of multiple sclerosis: A population-based case-control study. Mult Scler 16(7):855-861.
12. Kang JH, Chen YH, Lin HC (2010) Comorbidities amongst patients with multiple sclerosis: A population-based controlled study. Eur J Neurol 17(9):1215-1219.
13. Ried K (2006) Interpreting and understanding meta-analysis graphs - A practical guide. Aust Fam Physician 35(8):635-638.
14. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557-560.
15. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629-634.
16. Dogan S, Atakan N, Kurne A, Karabudak R (2011) High frequency of psoriasis in relatives in a Turkish multiple sclerosis cohort. Skinmed 9(1):11-13.
17. Annunziata P, Morana P, Giorgio A, Galeazzi M, Campanella V, Lore F et al (2003) High frequency of psoriasis in relatives is associated with early onset in an Italian multiple sclerosis cohort. Acta Neurol Scand 108(5):327-331.
18. Braverman LE, Utiger RD (1991) Introduction to hypothyroidism. In: Braverman LE, Utiger RD (eds) The thyroid, a fundamental and clinical text, 6th edn. JB Lippincott, Philadelphia, pp 919-920.
19. Iwasaki Y, Kinoshita M (1988) Thyroid function in patients with multiple sclerosis. Acta Neurol Scand 77(3):269.
20. Wei T, Lightman SL (1997) The neuroendocrine axis in patients with multiple sclerosis. Brain 120(Pt 6):1067-1076.
21. Spadaro M, Amendolea MA, Mazzucconi MG, Fantozzi R, Di Lello R, Zangari P et al (1999) Autoimmunity in multiple sclerosis: study of a wide spectrum of autoantibodies. Mult Scler 5(2):121-125.
22. Karni A, Abramsky O (1999) Association of MS with thyroid disorders. Neurology 53(4):883-885.
23. Niederwieser G, Buchinger W, Bonelli RM, Berghold A, Reisecker F, Koltringer P et al (2003) Prevalence of autoimmune thyroiditis and non-immune thyroid disease in multiple sclerosis. J Neurol 250(6):672-675.
24. Edwards LJ, Constantinescu CS (2004) A prospective study of conditions associated with multiple sclerosis in a cohort of 658 consecutive outpatients attending a multiple sclerosis clinic. Mult Scler 10(5):575-581.
25. Sloka JS, Phillips PW, Stefanelli M, Joyce C (2005) Co-occurrence of autoimmune thyroid disease in a multiple sclerosis cohort. J Autoimmun Dis 2:9.
26. Munteis E, Cano JF, Flores JA, Martinez-Rodriguez JE, Miret M, Roquer J (2007) Prevalence of autoimmune thyroid disorders in a Spanish multiple sclerosis cohort. Eur J Neurol 14(9):1048-1052.
27. Ramagopalan SV, Dyment DA, Valdar W, Herrera BM, Criscuoli M, Yee IM et al (2007) Autoimmune disease in families with multiple sclerosis: A population-based study. Lancet Neurol 6(7):604- 610.
28. Henderson RD, Bain CJ, Pender MP (2000) The occurrence of autoimmune diseases in patients with multiple sclerosis and their families. J Clin Neurosci 7(5):434-437.
29. Seyfert S, Klapps P, Meisel C, Fischer T, Junghan U (1990) Multiple sclerosis and other immunologic diseases. Acta Neurol Scand 81(1):37-42.
30. Midgard R, Gronning M, Riise T, Kvale G, Nyland H (1996) Multiple sclerosis and chronic inflammatory diseases. A casecontrol study. Acta Neurol Scand 93(5):322-328.
31. Laroni A, Calabrese M, Perini P, Albergoni MP, Ranzato F, Tiberio M et al (2006) Multiple sclerosis and autoimmune diseases: epidemiology and HLA-DR association in North-east Italy. J Neurol 253(5):636-639.
32. De Keyser J (1988) Autoimmunity in multiple sclerosis. Neurology 38(3):371-374.
33. Wynn DR, Rodriguez M, O'Fallon WM, Kurland LT (1990) A reappraisal of the epidemiology of multiple sclerosis in Olmsted county, Minnesota. Neurology 40(5):780-786.
34. Broadley SA, Deans J, Sawcer SJ, Clayton D, Compston DA (2000) Autoimmune disease in first-degree relatives of patients with multiple sclerosis. A UK survey. Brain 123(Pt 6):1102-1111.
35. Deretzi G, Kountouras J, Koutlas E, Zavos C, Polyzos S, Rudolf J et al (2010) Familial prevalence of autoimmune disorders inmultiple sclerosis in Northern Greece. Mult Scler 16(9):1091-1101.
36. Ioppoli C, Meucci G, Mariotti S, Martino E, Lippi A, Gironelli L et al (1990) Circulating thyroid and gastric parietal cell autoantibodies in patients with multiple sclerosis. Ital J Neurol Sci 11(1):31-36.
37. Annunziata P, Lore F, Venturini E, Morana P, Guarino E, Borghi S et al (1999) Early synthesis and correlation of serum antithyroid antibodies with clinical parameters in multiple sclerosis. J Neurol Sci 168(1):32-36.
38. Durelli L, Ferrero B, Oggero A, Verdun E, Ghezzi A, Montanari E et al (2001) Thyroid function and autoimmunity during interferon beta-1b treatment: A multicenter prospective study. J Clin Endocrinol Metab 86(8):3525-3532.
39. Wei Q, Bundell C, Wu JS, Castley A, James I, Hollingsworth P et al (2010) Low level of systemic autoimmunity in Western Australian multiple sclerosis patients. Mult Scler 16(3):351-354.
40. Dallmeijer AJ, Beckerman H, de Groot V, van de Port IG, Lankhorst GJ, Dekker J (2009) Long-term effect of comorbidity on the course of physical functioning in patients after stroke and with multiple sclerosis. J Rehabil Med 41(5):322-326.
41. Marrosu MG, Cocco E, Lai M, Spinicci G, Pischedda MP, Contu P (2002) Patients with multiple sclerosis and risk of type 1 diabetes mellitus in Sardinia, Italy: A cohort study. Lancet 359(9316):1461-1465.
42. Wertman E, Zilber N, Abramsky O (1992) An association between multiple sclerosis and type I diabetes mellitus. J Neurol 239(1):43-45.
43. Lindegard B (1985) Diseases associated with multiple sclerosis and epilepsy. A population cohort study of 159, 200 middle-aged, urban, native Swedes observed over 10 years (1970-79). Acta Neurol Scand 71(4):267-277.
44. Warren S, Warren KG (1981) Multiple sclerosis and associated diseases: A relationship to diabetes mellitus. Can J Neurol Sci 8(1):35-39.
45. Warren SA, Warren KG (1982) Multiple sclerosis and diabetes mellitus: further evidence of a relationship. Can J Neurol Sci 9(4):415-419.
46. Pokorny CS, Beran RG, Pokorny MJ (2007) Association between ulcerative colitis and multiple sclerosis. Intern Med J 37(10):721-724.
47. Michielsens B, Walravens M, Vermylen J, Carton H (1991) Diagnostic significance of antinuclear antibodies in neurologic patients. Acta Neurol Scand 84(2):102-106.
48. Dore-Duffy P, Donaldson JO, Rothman BL, Zurier RB (1982) Antinuclear antibodies in multiple sclerosis. Arch Neurol 39(8):504-506.
49. Szmyrka-Kaczmarek M, Pokryszko-Dragan A, Pawlik B, Gruszka E, Korman L, Podemski R et al (2012) Antinuclear and antiphospholipid antibodies in patients with multiple sclerosis. Lupus 21(4):412-420.
50. Hyypia T, Viander M, Reunanen M, Salmi A (1982) Antibodies to nuclear and smooth muscle antigens in multiple sclerosis and control patients. Acta Neurol Scand 65(6):629-635.
51. Hawkins BR, Cheah PS, Dawkins RL, Whittingham S, Burger HG, Patel Y et al (1980) Diagnostic significance of thyroid microsomal antibodies in randomly selected population. Lancet 2(8203):1057-1059.